 It's quite expensive to bring a new drug to market, and the timeline is 10 years or more. If we first look at drugs that are already approved, it's a more effective way to use our research dollars. So how would we find new drugs for an emerging pandemic like the COVID-19 crisis? The AI looks for patients who have pairs of diseases where a drug that they're taking for one disease actually turns out to be beneficial for the second disease. We think that technology will let us find drugs that can potentially address disease really quickly.